BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 15743916)

  • 1. Microdeletion of target sites for insulator protein CTCF in a chromosome 11p15 imprinting center in Beckwith-Wiedemann syndrome and Wilms' tumor.
    Prawitt D; Enklaar T; Gärtner-Rupprecht B; Spangenberg C; Oswald M; Lausch E; Schmidtke P; Reutzel D; Fees S; Lucito R; Korzon M; Brozek I; Limon J; Housman DE; Pelletier J; Zabel B
    Proc Natl Acad Sci U S A; 2005 Mar; 102(11):4085-90. PubMed ID: 15743916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microdeletions in the human H19 DMR result in loss of IGF2 imprinting and Beckwith-Wiedemann syndrome.
    Sparago A; Cerrato F; Vernucci M; Ferrero GB; Silengo MC; Riccio A
    Nat Genet; 2004 Sep; 36(9):958-60. PubMed ID: 15314640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of the IGF2/H19 imprinting control region uncovers new genetic defects, including mutations of OCT-binding sequences, in patients with 11p15 fetal growth disorders.
    Demars J; Shmela ME; Rossignol S; Okabe J; Netchine I; Azzi S; Cabrol S; Le Caignec C; David A; Le Bouc Y; El-Osta A; Gicquel C
    Hum Mol Genet; 2010 Mar; 19(5):803-14. PubMed ID: 20007505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Different mechanisms cause imprinting defects at the IGF2/H19 locus in Beckwith-Wiedemann syndrome and Wilms' tumour.
    Cerrato F; Sparago A; Verde G; De Crescenzo A; Citro V; Cubellis MV; Rinaldi MM; Boccuto L; Neri G; Magnani C; D'Angelo P; Collini P; Perotti D; Sebastio G; Maher ER; Riccio A
    Hum Mol Genet; 2008 May; 17(10):1427-35. PubMed ID: 18245780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inherited and Sporadic Epimutations at the IGF2-H19 locus in Beckwith-Wiedemann syndrome and Wilms' tumor.
    Riccio A; Sparago A; Verde G; De Crescenzo A; Citro V; Cubellis MV; Ferrero GB; Silengo MC; Russo S; Larizza L; Cerrato F
    Endocr Dev; 2009; 14():1-9. PubMed ID: 19293570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of genomic imprinting in Wilms' tumour and overgrowth disorders.
    Reeve AE
    Med Pediatr Oncol; 1996 Nov; 27(5):470-5. PubMed ID: 8827076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms causing imprinting defects in familial Beckwith-Wiedemann syndrome with Wilms' tumour.
    Sparago A; Russo S; Cerrato F; Ferraiuolo S; Castorina P; Selicorni A; Schwienbacher C; Negrini M; Ferrero GB; Silengo MC; Anichini C; Larizza L; Riccio A
    Hum Mol Genet; 2007 Feb; 16(3):254-64. PubMed ID: 17158821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alterations of H19 imprinting and IGF2 replication timing are infrequent in Beckwith-Wiedemann syndrome.
    Squire JA; Li M; Perlikowski S; Fei YL; Bayani J; Zhang ZM; Weksberg R
    Genomics; 2000 May; 65(3):234-42. PubMed ID: 10857747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular biology of Beckwith-Wiedemann syndrome.
    Weksberg R; Squire JA
    Med Pediatr Oncol; 1996 Nov; 27(5):462-9. PubMed ID: 8827075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microdeletion and IGF2 loss of imprinting in a cascade causing Beckwith-Wiedemann syndrome with Wilms' tumor.
    Prawitt D; Enklaar T; Gärtner-Rupprecht B; Spangenberg C; Lausch E; Reutzel D; Fees S; Korzon M; Brozek I; Limon J; Housman DE; Pelletier J; Zabel B
    Nat Genet; 2005 Aug; 37(8):785-6; author reply 786-7. PubMed ID: 16049499
    [No Abstract]   [Full Text] [Related]  

  • 11. A novel de novo point mutation of the OCT-binding site in the IGF2/H19-imprinting control region in a Beckwith-Wiedemann syndrome patient.
    Higashimoto K; Jozaki K; Kosho T; Matsubara K; Fuke T; Yamada D; Yatsuki H; Maeda T; Ohtsuka Y; Nishioka K; Joh K; Koseki H; Ogata T; Soejima H
    Clin Genet; 2014 Dec; 86(6):539-44. PubMed ID: 24299031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of the methylation status of the KCNQ1OT and H19 genes in leukocyte DNA for the diagnosis and prognosis of Beckwith-Wiedemann syndrome.
    Gaston V; Le Bouc Y; Soupre V; Burglen L; Donadieu J; Oro H; Audry G; Vazquez MP; Gicquel C
    Eur J Hum Genet; 2001 Jun; 9(6):409-18. PubMed ID: 11436121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imprinting status of 11p15 genes in Beckwith-Wiedemann syndrome patients with CDKN1C mutations.
    Li M; Squire J; Shuman C; Fei YL; Atkin J; Pauli R; Smith A; Nishikawa J; Chitayat D; Weksberg R
    Genomics; 2001 Jun; 74(3):370-6. PubMed ID: 11414765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid detection of methylation change at H19 in human imprinting disorders using methylation-sensitive high-resolution melting.
    Wojdacz TK; Dobrovic A; Algar EM
    Hum Mutat; 2008 Oct; 29(10):1255-60. PubMed ID: 18473334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel deletion in 11p15.5 imprinting center region 1 in a patient with Beckwith-Wiedemann syndrome provides insight into distal enhancer regulation and tumorigenesis.
    Bachmann N; Crazzolara R; Bohne F; Kotzot D; Maurer K; Enklaar T; Prawitt D; Bergmann C
    Pediatr Blood Cancer; 2017 Mar; 64(3):. PubMed ID: 27650505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel IGF2/H19 domain triplication in the 11p15.5 imprinting region causing either Beckwith-Wiedemann or Silver-Russell syndrome in a single family.
    Jurkiewicz D; Kugaudo M; Skórka A; Śmigiel R; Smyk M; Ciara E; Chrzanowska K; Krajewska-Walasek M
    Am J Med Genet A; 2017 Jan; 173(1):72-78. PubMed ID: 27612309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extensive investigation of the IGF2/H19 imprinting control region reveals novel OCT4/SOX2 binding site defects associated with specific methylation patterns in Beckwith-Wiedemann syndrome.
    Abi Habib W; Azzi S; Brioude F; Steunou V; Thibaud N; Das Neves C; Le Jule M; Chantot-Bastaraud S; Keren B; Lyonnet S; Michot C; Rossi M; Pasquier L; Gicquel C; Rossignol S; Le Bouc Y; Netchine I
    Hum Mol Genet; 2014 Nov; 23(21):5763-73. PubMed ID: 24916376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paternally inherited submicroscopic duplication at 11p15.5 implicates insulin-like growth factor II in overgrowth and Wilms' tumorigenesis.
    Algar EM; St Heaps L; Darmanian A; Dagar V; Prawitt D; Peters GB; Collins F
    Cancer Res; 2007 Mar; 67(5):2360-5. PubMed ID: 17325026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular subtypes and phenotypic expression of Beckwith-Wiedemann syndrome.
    Cooper WN; Luharia A; Evans GA; Raza H; Haire AC; Grundy R; Bowdin SC; Riccio A; Sebastio G; Bliek J; Schofield PN; Reik W; Macdonald F; Maher ER
    Eur J Hum Genet; 2005 Sep; 13(9):1025-32. PubMed ID: 15999116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relaxation of insulin-like growth factor 2 imprinting and discordant methylation at KvDMR1 in two first cousins affected by Beckwith-Wiedemann and Klippel-Trenaunay-Weber syndromes.
    Sperandeo MP; Ungaro P; Vernucci M; Pedone PV; Cerrato F; Perone L; Casola S; Cubellis MV; Bruni CB; Andria G; Sebastio G; Riccio A
    Am J Hum Genet; 2000 Mar; 66(3):841-7. PubMed ID: 10712200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.